InvestorsHub Logo

misiu143

01/05/17 11:33 AM

#8834 RE: 123boom #8832

I am hoping adjunct still will be Q1 , we will see what Dr P will say during conference.

The only explanation I can think of is that those patients with resistance to some of HAART , are acutely sick.

They cant accept patients for a study with acute sickness , fever etc , for at least one week before.

I cant think of any other reason. I wish I know.




gestalt2

01/05/17 11:37 AM

#8836 RE: 123boom #8832

even though i like everyone want the trials to move as fast as possible - it is better to make sure we have the right patients so the data is the best possible with few questions on pro 140's benefit.

d0lphint0m

01/05/17 11:43 AM

#8838 RE: 123boom #8832

I don't think there is any doubt that the colon and MS news adds value to the BO. It is a good question to ask today on CC, how much value "do they perceive" could be tacked on because of this added news. I would but will be on the road so can't participate in the call.